{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:31:26Z","timestamp":1791210686607,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3812,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.ymthe.2005.11.021","type":"journal-article","created":{"date-parts":[[2006,2,8]],"date-time":"2006-02-08T13:25:25Z","timestamp":1139405125000},"page":"1006-1015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Sustained FVIII Expression and Phenotypic Correction of Hemophilia A in Neonatal Mice Using an Endothelial-Targeted Sleeping Beauty Transposon"],"prefix":"10.1016","volume":"13","author":[{"given":"Li","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathryn","family":"Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley S.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2005.11.021_bib1","series-title":"Hematology: Basic Principles and Practice","first-page":"1648","article-title":"Clinical aspects of and therapy for hemophilia A","author":"Brettler","year":"1995"},{"key":"10.1016\/j.ymthe.2005.11.021_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0268-960X(03)00038-9","article-title":"Prophylactic factor replacement in hemophilia","volume":"18","author":"Carcao","year":"2004","journal-title":"Blood Rev."},{"key":"10.1016\/j.ymthe.2005.11.021_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V84.1.3.3","article-title":"A practical guide to the evaluation and treatment of hemophilia","volume":"84","author":"Furie","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.021_bib4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/sj.gt.3302024","article-title":"Gene therapy progress and prospects: gene therapy for the hemophilias","volume":"10","author":"Walsh","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2005.11.021_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05231.x","article-title":"A review of gene therapy for haematological disorders","volume":"128","author":"Nathwani","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymthe.2005.11.021_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-2004-825633","article-title":"Nonviral gene therapy approaches to hemophilia","volume":"30","author":"Gomez-Vargas","year":"2004","journal-title":"Semin. Thromb. Hemostasis"},{"key":"10.1016\/j.ymthe.2005.11.021_bib7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.gt.3302037","article-title":"Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy","volume":"10","author":"Jooss","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2005.11.021_bib8","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/JVI.76.9.4580-4590.2002","article-title":"Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors","volume":"76","author":"Zaiss","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2005.11.021_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ng1179","article-title":"AAV serotype 2 vectors preferentially integrate into active genes in mice","volume":"34","author":"Nakai","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2005.11.021_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1479-0556-2-9","article-title":"The use of retroviral vectors for gene therapy\u2014What are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery","volume":"2","author":"Anson","year":"2004","journal-title":"Genet. Vaccines Ther."},{"key":"10.1016\/j.ymthe.2005.11.021_bib11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/104303403322319381","article-title":"High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors","volume":"14","author":"Miao","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2005.11.021_bib12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1089\/hum.2005.16.558","article-title":"Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo","volume":"16","author":"Riu","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2005.11.021_bib13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)80436-5","article-title":"Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells","volume":"91","author":"Ivics","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2005.11.021_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ymthe.2003.11.009","article-title":"Sleeping Beauty transposition: biology and applications for molecular therapy","volume":"9","author":"Izsvak","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.11.021_bib15","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1073\/pnas.090527097","article-title":"A phage integrase directs efficient site-specific integration in human cells","volume":"97","author":"Groth","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2005.11.021_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/75568","article-title":"Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system","volume":"25","author":"Yant","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2005.11.021_bib17","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nbt753","article-title":"Site-specific genomic integration produces therapeutic Factor IX levels in mice","volume":"20","author":"Olivares","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2005.11.021_bib18","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood-2004-09-3496","article-title":"Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system","volume":"105","author":"Ohlfest","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.021_bib19","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ymthe.2005.01.010","article-title":"A direct comparison of two nonviral gene therapy vectors for somatic integration: in vivo evaluation of the bacteriophage integrase phiC31 and the Sleeping Beauty transposase","volume":"11","author":"Ehrhardt","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.11.021_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2141.2004.05168.x","article-title":"Inhibitors in congenital coagulation disorders","volume":"127","author":"Key","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymthe.2005.11.021_bib21","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood.V91.9.3273","article-title":"Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy","volume":"91","author":"Connelly","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.021_bib22","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V95.5.1594.005k34_1594_1599","article-title":"Sustained expression of human factor VIII in mice using a parvovirus-based vector","volume":"95","author":"Chao","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.021_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/blood.V97.1.107","article-title":"Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs","volume":"97","author":"Gallo-Penn","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.021_bib24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1525-0016(03)00073-X","article-title":"Efficient production of human FVIII in hemophilic mice using lentiviral vectors","volume":"7","author":"Kootstra","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.11.021_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2004-825635","article-title":"Immune implications of gene therapy for hemophilia","volume":"30","author":"Herzog","year":"2004","journal-title":"Semin. Thromb. Hemostasis"},{"key":"10.1016\/j.ymthe.2005.11.021_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ymthe.2004.04.009","article-title":"Naked DNA transfer of factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice","volume":"10","author":"Ye","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.11.021_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/clim.1999.4724","article-title":"Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration","volume":"92","author":"Brockstedt","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ymthe.2005.11.021_bib28","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1182\/blood-2001-11-0067","article-title":"Dangerous liaisons: the role of \u201cdanger\u201d signals in the immune response to gene therapy","volume":"100","author":"Brown","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.021_bib29","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1182\/blood-2002-07-2146","article-title":"Humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells","volume":"101","author":"De Geest","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.021_bib30","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1538-7933.2004.00671.x","article-title":"Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A","volume":"2","author":"Madoiwa","year":"2004","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ymthe.2005.11.021_bib31","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1182\/blood-2002-03-0779","article-title":"In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor","volume":"101","author":"Waddington","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.021_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood-2003-06-2181","article-title":"Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogs","volume":"103","author":"Zhang","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.021_bib33","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1073\/pnas.0409249102","article-title":"Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy","volume":"102","author":"Xu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2005.11.021_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ymthe.2004.04.006","article-title":"Endothelial targeting of the Sleeping Beauty transposon within lung","volume":"10","author":"Liu","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.11.021_bib35","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1055\/s-0037-1616143","article-title":"Tissue distribution of factor VIII gene expression in vivo\u2014A closer look","volume":"86","author":"Hollestelle","year":"2001","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.ymthe.2005.11.021_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/blood.V99.2.457","article-title":"Use of blood outgrowth endothelial cells for gene therapy for hemophilia A","volume":"99","author":"Lin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2005.11.021_bib37","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1055\/s-0038-1648506","article-title":"The structure and function of von Willebrand factor","volume":"67","author":"Ruggeri","year":"1992","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.ymthe.2005.11.021_bib38","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0022-2836(02)00237-1","article-title":"Structure-function analysis of the inverted terminal repeats of the Sleeping Beauty transposon","volume":"318","author":"Cui","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymthe.2005.11.021_bib39","unstructured":"Baus, J., Liu, L., Heggestad, A.D., Sanz, S., Fletcher, B.S. (in press) Hyperactive transposase mutants of the Sleeping Beauty transposon. Mol. Ther."},{"key":"10.1016\/j.ymthe.2005.11.021_bib40","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/sj.gt.3300717","article-title":"Polyethylenimine-based intravenous delivery of transgenes to mouse lung","volume":"5","author":"Goula","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2005.11.021_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1521-2254(200003\/04)2:2<128::AID-JGM95>3.0.CO;2-W","article-title":"Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse","volume":"2","author":"Zou","year":"2000","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2005.11.021_bib42","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI200316887","article-title":"Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer","volume":"111","author":"Mingozzi","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2005.11.021_bib43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature03681","article-title":"Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse","volume":"436","author":"Collier","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2005.11.021_bib44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature03691","article-title":"Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system","volume":"436","author":"Dupuy","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2005.11.021_bib45","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/hmg\/11.14.1615","article-title":"In vivo electrotransfer of the cardiotrophin-1 gene into skeletal muscle slows down progression of motor neuron degeneration in pmn mice","volume":"11","author":"Lesbordes","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2005.11.021_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1432-1033.1995.tb20776.x","article-title":"Novel forms of B-domain-deleted recombinant factor VIII molecules: construction and biochemical characterization","volume":"232","author":"Lind","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ymthe.2005.11.021_bib47","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/sj.leu.2402557","article-title":"Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression","volume":"16","author":"Fletcher","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2005.11.021_bib48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A","volume":"10","author":"Bi","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2005.11.021_bib49","first-page":"612","article-title":"A more uniform measurement of factor VIII inhibitors","volume":"34","author":"Kasper","year":"1975","journal-title":"Thromb. Diath. Haemorrh."},{"key":"10.1016\/j.ymthe.2005.11.021_bib50","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1073\/pnas.062630599","article-title":"Mammalian germ-line transgenesis by transposition","volume":"99","author":"Dupuy","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001605017387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001605017387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:50:27Z","timestamp":1761501027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001605017387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S1525001605017387"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2005.11.021","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained FVIII Expression and Phenotypic Correction of Hemophilia A in Neonatal Mice Using an Endothelial-Targeted Sleeping Beauty Transposon","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2005.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}